Skip to main content
Top
Published in: BMC Gastroenterology 1/2017

Open Access 01-12-2017 | Research article

Alteration of gut microbiota in association with cholesterol gallstone formation in mice

Authors: Qihan Wang, Long Jiao, Chuanqi He, Haidong Sun, Qu Cai, Tianquan Han, Hai Hu

Published in: BMC Gastroenterology | Issue 1/2017

Login to get access

Abstract

Background

The gut microbiome exerts extensive roles in metabolism of nutrients, pharmaceuticals, organic chemicals. Little has been known for the role of gut microbiota in regulating cholesterol and bile acids in association with gallstone formation. This study investigated the changes in the composition of gut microbiota in mice fed with lithogenic diet (LD).

Methods

Adult male C57BL/6 J mice were fed with either lithogenic diet (1.25% cholesterol and 0.5% cholic acid) or chow diet as control for 56 days. The fecal microbiota were determined by 16S rRNA gene sequencing.

Results

LD led to formation of cholesterol gallstone in mice. The richness and alpha diversity of gut microbial reduced in mice fed with LD. Firmicutes was significantly decreased from 59.71% under chow diet to 31.45% under LD, P < 0.01, as well as the ratio of Firmicutes to Bacteroidetes. Differences in gut microbiota composition were also observed at phylum, family and genus levels between the two groups.

Conclusion

Our results suggested that gut microbiota dysbiosis might play an important role in the pathogenesis of cholesterol gallstone formation in mice.
Appendix
Available only for authorised users
Literature
1.
go back to reference Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117:632–9.CrossRefPubMed Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117:632–9.CrossRefPubMed
2.
go back to reference Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11.CrossRefPubMed Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–11.CrossRefPubMed
3.
go back to reference Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7:132–40.CrossRefPubMed Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7:132–40.CrossRefPubMed
4.
go back to reference Zhu L, Aili A, Zhang C, Saiding A, Abudureyimu K. Prevalence of and risk factors for gallstones in Uighur and Han Chinese. World J Gastroenterol. 2014;20:14942–9.CrossRefPubMedPubMedCentral Zhu L, Aili A, Zhang C, Saiding A, Abudureyimu K. Prevalence of and risk factors for gallstones in Uighur and Han Chinese. World J Gastroenterol. 2014;20:14942–9.CrossRefPubMedPubMedCentral
5.
go back to reference Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin N Am. 1991;20:1–19. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin N Am. 1991;20:1–19.
6.
7.
go back to reference Jiang ZY, Parini P, Eggertsen G, Davis MA, Hu H, Suo GJ, Zhang SD, Rudel LL, Han TQ, Einarsson C. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J Lipid Res. 2008;49:464–72.CrossRefPubMed Jiang ZY, Parini P, Eggertsen G, Davis MA, Hu H, Suo GJ, Zhang SD, Rudel LL, Han TQ, Einarsson C. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J Lipid Res. 2008;49:464–72.CrossRefPubMed
8.
go back to reference Wang HH, Portincasa P, Mendezsanchez N, Uribe M, Wang DQH. Effect of Ezetimibe on the Prevention and Dissolution of Cholesterol Gallstones. Gastroenterology. 2008;134:2101–10.CrossRefPubMedPubMedCentral Wang HH, Portincasa P, Mendezsanchez N, Uribe M, Wang DQH. Effect of Ezetimibe on the Prevention and Dissolution of Cholesterol Gallstones. Gastroenterology. 2008;134:2101–10.CrossRefPubMedPubMedCentral
9.
go back to reference Wang DQ, Cohen DE, Carey MC. Biliary lipids and cholesterol gallstone disease. J Lipid Res. 2009;(50 Suppl):S406–11. Wang DQ, Cohen DE, Carey MC. Biliary lipids and cholesterol gallstone disease. J Lipid Res. 2009;(50 Suppl):S406–11.
11.
go back to reference Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17:225–35.CrossRefPubMed Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013;17:225–35.CrossRefPubMed
12.
go back to reference Liong MT, Shah NP. Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of lactobacilli strains. Int Dairy J. 2005;15:391–8.CrossRef Liong MT, Shah NP. Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of lactobacilli strains. Int Dairy J. 2005;15:391–8.CrossRef
13.
go back to reference Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr. 1974;27:1341–7.PubMed Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr. 1974;27:1341–7.PubMed
14.
go back to reference Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47:241–59.CrossRefPubMed Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47:241–59.CrossRefPubMed
15.
go back to reference Stellwag EJ, Hylemon PB. 7alpha-Dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum. J Lipid Res. 1979;20:325–33.PubMed Stellwag EJ, Hylemon PB. 7alpha-Dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum. J Lipid Res. 1979;20:325–33.PubMed
16.
go back to reference Shao D, Wang Y, Huang Q, Shi J, Yang H, Pan Z, Jin M, Zhao H, Xu X. Cholesterol-Lowering Effects and Mechanisms in View of Bile Acid Pathway of Resveratrol and Resveratrol Glucuronides. J Food Sci. 2016. Shao D, Wang Y, Huang Q, Shi J, Yang H, Pan Z, Jin M, Zhao H, Xu X. Cholesterol-Lowering Effects and Mechanisms in View of Bile Acid Pathway of Resveratrol and Resveratrol Glucuronides. J Food Sci. 2016.
17.
go back to reference Reynier MO, Montet JC, Gerolami A, Marteau C, Crotte C, Montet AM, Mathieu S. Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J Lipid Res. 1981;22:467–73.PubMed Reynier MO, Montet JC, Gerolami A, Marteau C, Crotte C, Montet AM, Mathieu S. Comparative effects of cholic, chenodeoxycholic, and ursodeoxycholic acids on micellar solubilization and intestinal absorption of cholesterol. J Lipid Res. 1981;22:467–73.PubMed
18.
go back to reference Samuelsson B. Bile acids and steroids. 96. On the mechanism of the biological formation of deoxycholic acid. J Biol Chem. 1960;235:361–66. Samuelsson B. Bile acids and steroids. 96. On the mechanism of the biological formation of deoxycholic acid. J Biol Chem. 1960;235:361–66.
19.
go back to reference Kurdi P, Kawanishi K, Mizutani K, Yokota A. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol. 2006;188:1979–86.CrossRefPubMedPubMedCentral Kurdi P, Kawanishi K, Mizutani K, Yokota A. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol. 2006;188:1979–86.CrossRefPubMedPubMedCentral
21.
go back to reference Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9:577–89.CrossRefPubMed Flint HJ, Scott KP, Louis P, Duncan SH. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol. 2012;9:577–89.CrossRefPubMed
22.
go back to reference Tai N, Wong FS, Wen L. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord. 2015;16:55–65.CrossRefPubMedPubMedCentral Tai N, Wong FS, Wen L. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Rev Endocr Metab Disord. 2015;16:55–65.CrossRefPubMedPubMedCentral
23.
go back to reference Zhou J, Wu L, Deng Y, Zhi X, Jiang YH, Tu Q, Xie J, Nostrand JDV, He Z, Yang Y. Reproducibility and quantitation of amplicon sequencing-based detection. Isme J. 2011;5:1303–13.CrossRefPubMedPubMedCentral Zhou J, Wu L, Deng Y, Zhi X, Jiang YH, Tu Q, Xie J, Nostrand JDV, He Z, Yang Y. Reproducibility and quantitation of amplicon sequencing-based detection. Isme J. 2011;5:1303–13.CrossRefPubMedPubMedCentral
24.
go back to reference Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, Carey MC, Fox JG. Identification of cholelithogenic enterohepatic Helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology. 2005;128:1023–33.CrossRefPubMed Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, Carey MC, Fox JG. Identification of cholelithogenic enterohepatic Helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology. 2005;128:1023–33.CrossRefPubMed
25.
go back to reference Jacqueline J, Fremont-Rahl ZG, Umana CT, Whary MT, Taylor NS, Sureshkumar M, Carey MC, Fox JG, Maurer KJ. An Analysis of the Role of the Indigenous Microbiota in Cholesterol Gallstone Pathogenesis. Plos One. 2013;8:e70657-e70657. Jacqueline J, Fremont-Rahl ZG, Umana CT, Whary MT, Taylor NS, Sureshkumar M, Carey MC, Fox JG, Maurer KJ. An Analysis of the Role of the Indigenous Microbiota in Cholesterol Gallstone Pathogenesis. Plos One. 2013;8:e70657-e70657.
26.
27.
go back to reference Thomas LA, Veysey MJ, Bathgate T, King A, French G, Smeeton NC, Murphy GM, Dowling RH. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis ☆. Gastroenterology. 2000;119:806–15.CrossRefPubMed Thomas LA, Veysey MJ, Bathgate T, King A, French G, Smeeton NC, Murphy GM, Dowling RH. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis ☆. Gastroenterology. 2000;119:806–15.CrossRefPubMed
28.
go back to reference Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev. 2005;29:625–51.CrossRefPubMed Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev. 2005;29:625–51.CrossRefPubMed
29.
go back to reference Berr F, Schreiber E, Frick U. Interrelationships of bile acid and phospholipid fatty acid species with cholesterol saturation of duodenal bile in health and gallstone disease. Hepatology. 1992;16:71–81.CrossRefPubMed Berr F, Schreiber E, Frick U. Interrelationships of bile acid and phospholipid fatty acid species with cholesterol saturation of duodenal bile in health and gallstone disease. Hepatology. 1992;16:71–81.CrossRefPubMed
30.
go back to reference Hussaini SH, Pereira SP, Murphy GM, Dowling RH. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile. Hepatology. 1995;22:1735–44.PubMed Hussaini SH, Pereira SP, Murphy GM, Dowling RH. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile. Hepatology. 1995;22:1735–44.PubMed
31.
go back to reference Berr F, Kullakublick GA, Paumgartner G, Münzing W, Hylemon PB. 7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology. 1996;111:1611–20.CrossRefPubMed Berr F, Kullakublick GA, Paumgartner G, Münzing W, Hylemon PB. 7 alpha-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology. 1996;111:1611–20.CrossRefPubMed
32.
go back to reference Tanaka H, Doesburg K, Iwasaki T, Mierau I. Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci. 1999;82:2530–5.CrossRefPubMed Tanaka H, Doesburg K, Iwasaki T, Mierau I. Screening of lactic acid bacteria for bile salt hydrolase activity. J Dairy Sci. 1999;82:2530–5.CrossRefPubMed
33.
go back to reference Klaver FA, Meer RVD. The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol. 1993;59:1120–4.PubMedPubMedCentral Klaver FA, Meer RVD. The assumed assimilation of cholesterol by Lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol. 1993;59:1120–4.PubMedPubMedCentral
34.
go back to reference Pato U, Surono IS. Koesnandar, Hosono A: Hypocholesterolemic effect of indigenous dadih lactic acid bacteria by deconjugation of bile salts. Asian Australas J Anim Sci. 2004;17:1741–5.CrossRef Pato U, Surono IS. Koesnandar, Hosono A: Hypocholesterolemic effect of indigenous dadih lactic acid bacteria by deconjugation of bile salts. Asian Australas J Anim Sci. 2004;17:1741–5.CrossRef
35.
go back to reference Sridevi N, Vishwe P, Prabhune A. Hypocholesteremic effect of bile salt hydrolase from Lactobacillus buchneri ATCC 4005. Food Res Int. 2009;42:516–20.CrossRef Sridevi N, Vishwe P, Prabhune A. Hypocholesteremic effect of bile salt hydrolase from Lactobacillus buchneri ATCC 4005. Food Res Int. 2009;42:516–20.CrossRef
36.
go back to reference Park YH, Kim JG, Shin YW, Kim HS, Kim YJ, Chun T, Kim SH, Whang KY. Effects of Lactobacillus acidophilus 43121 and a mixture of Lactobacillus casei and Bifidobacterium longum on the serum cholesterol level and fecal sterol excretion in hypercholesterolemia-induced pigs. Biosci Biotechnol Biochem. 2008;72:595–600.CrossRefPubMed Park YH, Kim JG, Shin YW, Kim HS, Kim YJ, Chun T, Kim SH, Whang KY. Effects of Lactobacillus acidophilus 43121 and a mixture of Lactobacillus casei and Bifidobacterium longum on the serum cholesterol level and fecal sterol excretion in hypercholesterolemia-induced pigs. Biosci Biotechnol Biochem. 2008;72:595–600.CrossRefPubMed
37.
go back to reference Lye HS, Rusul G, Liong MT. Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci. 2010;93:1383–92.CrossRefPubMed Lye HS, Rusul G, Liong MT. Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci. 2010;93:1383–92.CrossRefPubMed
38.
go back to reference Hueyshi L, Gulamrusul RA, Mintze L. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010;20:169–75.CrossRef Hueyshi L, Gulamrusul RA, Mintze L. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010;20:169–75.CrossRef
39.
go back to reference Hu X, Wang T, Liang S, Li W, Wu X, Jin F. Antibiotic-induced imbalances in gut microbiota aggravates cholesterol accumulation and liver injuries in rats fed a high-cholesterol diet. Appl Microbiol Biotechnol. 2015;99:9111–22.CrossRefPubMed Hu X, Wang T, Liang S, Li W, Wu X, Jin F. Antibiotic-induced imbalances in gut microbiota aggravates cholesterol accumulation and liver injuries in rats fed a high-cholesterol diet. Appl Microbiol Biotechnol. 2015;99:9111–22.CrossRefPubMed
40.
go back to reference Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213–23.CrossRefPubMedPubMedCentral Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213–23.CrossRefPubMedPubMedCentral
41.
go back to reference Hildebrandt MA, Hoffmann C, Sherrillmix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137:1–2.CrossRef Hildebrandt MA, Hoffmann C, Sherrillmix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137:1–2.CrossRef
42.
go back to reference Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1:6799–806.CrossRef Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1:6799–806.CrossRef
43.
go back to reference Jørgensen BP, Hansen JT, Krych L, Larsen C, Klein AB, Nielsen DS, Josefsen K, Hansen AK, Sørensen DB. A Possible Link between Food and Mood: Dietary Impact on Gut Microbiota and Behavior in BALB/c Mice. Plos One. 2013;9:e103398-e103398. Jørgensen BP, Hansen JT, Krych L, Larsen C, Klein AB, Nielsen DS, Josefsen K, Hansen AK, Sørensen DB. A Possible Link between Food and Mood: Dietary Impact on Gut Microbiota and Behavior in BALB/c Mice. Plos One. 2013;9:e103398-e103398.
44.
go back to reference Peter Kurdi KK. Kanako Mizutani, Atsushi Yokota: Mechanism of Growth Inhibition by Free Bile Acids in Lactobacilli and Bifidobacteria. J Bacteriol. 2006;188:1979–86.CrossRefPubMedPubMedCentral Peter Kurdi KK. Kanako Mizutani, Atsushi Yokota: Mechanism of Growth Inhibition by Free Bile Acids in Lactobacilli and Bifidobacteria. J Bacteriol. 2006;188:1979–86.CrossRefPubMedPubMedCentral
45.
go back to reference Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 2011;141:1773–81.CrossRefPubMed Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, Ogura Y, Hayashi T, Yokota A. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology. 2011;141:1773–81.CrossRefPubMed
46.
go back to reference Reunanen J, Kainulainen V, Huuskonen L, Ottman N, Belzer C, Huhtinen H, de Vos WM, Satokari R. Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol. 2015;81:3655–62.CrossRefPubMedPubMedCentral Reunanen J, Kainulainen V, Huuskonen L, Ottman N, Belzer C, Huhtinen H, de Vos WM, Satokari R. Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer. Appl Environ Microbiol. 2015;81:3655–62.CrossRefPubMedPubMedCentral
47.
go back to reference Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110:9066–71.CrossRefPubMedPubMedCentral Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110:9066–71.CrossRefPubMedPubMedCentral
Metadata
Title
Alteration of gut microbiota in association with cholesterol gallstone formation in mice
Authors
Qihan Wang
Long Jiao
Chuanqi He
Haidong Sun
Qu Cai
Tianquan Han
Hai Hu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2017
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-017-0629-2

Other articles of this Issue 1/2017

BMC Gastroenterology 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.